Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara, Benjamin A. Pinsky, Mehul S. Suthar, Lilin Lai, Meredith E. Davis-Gardner, Katharine Floyd, Maria W. Flowers, Jens Wrammert, Laila Hussaini, Caroline Ciric, Sarah Bechnak, Kathy Stephens, Barney S. Graham, Elham Bayat Mokhtari, Prakriti Mudvari, Eli Boritz, Adrian Creanga, Amarendra Pegu, Alexandrine Derrien-Colemyn, Amy R. Henry, Matthew Gagné, Daniel C. Douek, Malaya K. Sahoo, Mamdouh Sibai, Daniel Solis, Richard J. Webby, Trushar Jeevan, Thomas Fabrizio
Abstract
To assess infection and vaccine-Induced Neutralizing-Antibody activity against the SARS-CoV-2 B.1.617.1 (or kappa) and B.1.617.2 (or delta) variants.
Topics & Concepts
RashMedicineVaccinationReceiptImmunologyAntibody responseVirologyAntibodyDermatologyWorld Wide WebComputer scienceSARS-CoV-2 and COVID-19 ResearchDrug-Induced Adverse ReactionsHeparin-Induced Thrombocytopenia and Thrombosis